Project Grant R15CA287297
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$459K
Federal Agency
National Cancer Institute
Federal Grant Program
93.396
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $730,398 Project Grant under the Cancer Biology Research program (CFDA 93.396) to the Sloan-Kettering Institute for Cancer Research. The grant supports a 5-year research project investigating the relationship between inflammatory signaling in the leptomeninges (the membranes surrounding the brain and spinal cord) and the growth of leptomeningeal metastases, which are a lethal complication of cancer. The project leverages the institute's collection of...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $167,584 to the University of California, San Diego to generate human induced pluripotent stem cell (hiPSC)-derived models of atypical teratoid rhabdoid tumors (ATRTs). The goal is to investigate the cell of origin and identify therapeutic vulnerabilities for these aggressive pediatric brain cancers that lack standardized treatments. The research will leverage the Furnari Lab's existing...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), supports research to investigate the role of the developmental transcription factor ONECUT2 in the development of pineoblastoma, a rare type of childhood brain cancer. The $447,405 award to the University of Texas Southwestern Medical Center will fund a 5-year research project to determine if ONECUT2 is necessary for tumor development, how it...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $552,968 to the University of Pittsburgh to conduct research on the role of tRNA modifications in glioblastoma stem cell maintenance and translational reprogramming. The research aims to understand how metabolic regulation of tRNA modification enzymes and amino acid availability impacts tRNA landscapes and codon-biased translation in glioblastoma, a highly lethal form of brain cancer....
The National Cancer Institute (NCI) awarded a $113,372 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to The Washington University, a prominent private research institution in Missouri. The grant, effective March 1, 2025 through February 28, 2027, will support research to uncover the molecular mechanisms and understand the role of SERPINE family genes underlying rhabdoid tumorigenesis. The research aims to identify the molecular signatures and mechanisms driving...
The Project Grant award R35CA293978, provided by the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research), supports research to identify the mechanisms driving rapid evolution of cancer genomes. The $942,442 award to the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, MA will fund investigations into two catastrophic mutational processes in cancer, chromothripsis and chromoplexy. The research aims to better understand the mechanisms of chromosome fragmentation, DNA...
This National Cancer Institute (CFDA 93.396 Cancer Biology Research) Project Grant award of $560,297 to the Icahn School of Medicine at Mount Sinai supports research to functionally characterize oncofetal stem cells (ONFSCs) in colorectal cancer (CRC). The key objectives are to: Generate phenotypic transcriptional reporters to track the dynamics of LGR5+ cancer stem cells (CSCs) and ONFSCs, and use these to dissect the functional interplay between these stem cell populations. Employ a multi-omic...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $518,219.00 in funding to the University of Pittsburgh to conduct research on the molecular mechanisms underlying the development of cholangiocarcinoma (CCA), a challenging form of liver cancer. The research aims to elucidate the roles of the nuclear receptors FXR and CAR in promoting CCA progression, particularly in the context of cholestatic liver diseases that significantly increase...
The National Cancer Institute (NCI) awarded a $417,586 Project Grant (CFDA 93.396 - Cancer Biology Research) to The Broad Institute, Inc. to develop a "Platform for Multi-Modal Single Nucleus Spatial Genomics for Molecular Tumor Analysis." This 3-year project, commencing on August 1, 2024, aims to extend the institute's "Slide-Tags" single-cell spatial genomics technology to enable comprehensive profiling of human tumor samples. The project will integrate molecular, cellular,...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides funding to the University of Texas MD Anderson Cancer Center to conduct research aimed at understanding how mutations in the TP53 tumor suppressor gene drive pro-metastatic interactions between pancreatic cancer cells and the surrounding tumor microenvironment. The $453,304 award will fund a 5-year project focused on clarifying the signaling mechanisms by which mutant TP53 activates the...